AAAAAA
Results: 1-25/40
Authors:
Wapstra, FH
Navis, GJ
van Goor, H
van den Born, J
Berden, JHM
de Jong, PE
de Zeeuw, D
Citation: Fh. Wapstra et al., ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy, EXP NEPHROL, 9(1), 2001, pp. 21-27
Authors:
Hillege, HL
Janssen, WMT
Bak, AAA
Diercks, GFH
Grobbee, DE
Crijns, HJGM
van Gilst, WH
de Zeeuw, D
de Jong, PE
Citation: Hl. Hillege et al., Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity, J INTERN M, 249(6), 2001, pp. 519-526
Authors:
Buter, H
Navis, G
Dullaart, RPF
de Zeeuw, D
de Jong, PE
Citation: H. Buter et al., Time course of the antiproteinuric and renal haemodynamic responses to losartan in microalbuminuric IDDM, NEPH DIAL T, 16(4), 2001, pp. 771-775
Authors:
Haverdings, RFG
Haas, M
Greupink, AR
de Vries, PAM
Moolenaar, F
de Zeeuw, D
Meijer, DKF
Citation: Rfg. Haverdings et al., Potentials and limitations of the low-molecular-weight protein lysozyme asa carrier for renal drug targeting, RENAL FAIL, 23(3-4), 2001, pp. 397-409
Authors:
Laverman, GD
Henning, RH
de Jong, PE
Navis, G
de Zeeuw, D
Citation: Gd. Laverman et al., Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria, AM J KIDNEY, 38(6), 2001, pp. 1381-1384
Authors:
Boonstra, A
de Zeeuw, D
de Jong, PE
Navis, G
Citation: A. Boonstra et al., Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease, SEM NEPHROL, 21(6), 2001, pp. 580-592
Authors:
Jafar, TH
Stark, PC
Schmid, CH
Landa, M
Maschio, G
Marcantoni, C
de Jong, PE
de Zeeuw, D
Shahinfar, S
Ruggenenti, P
Remuzzi, G
Levey, AS
Citation: Th. Jafar et al., Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease, KIDNEY INT, 60(3), 2001, pp. 1131-1140
Authors:
Brenner, BM
Cooper, ME
de Zeeuw, D
Keane, WF
Mitch, WE
Parving, HH
Remuzzi, G
Snapinn, SM
Zhang, ZX
Shahinfar, S
Citation: Bm. Brenner et al., Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N ENG J MED, 345(12), 2001, pp. 861-869
Authors:
Filipeanu, CM
Brailoiu, E
Henning, RH
Deelman, LE
de Zeeuw, D
Nelemans, SA
Citation: Cm. Filipeanu et al., Intracellular angiotensin II inhibits heterologous receptor stimulated Ca2+ entry, LIFE SCI, 70(2), 2001, pp. 171-180
Authors:
Boonstra, AH
Gschwend, S
Kocks, MJA
Buikema, H
de Zeeuw, D
Navis, GJ
Citation: Ah. Boonstra et al., Does a low-salt diet exert a protective effect on endothelial function in normal rats?, J LA CL MED, 138(3), 2001, pp. 200-205
Authors:
Roest, M
Banga, JD
Janssen, WMT
Grobbee, DE
Sixma, JF
de Jong, PE
de Zeeuw, D
van der Schouw, YT
Citation: M. Roest et al., Excessive urinary albumin levels are associated with future cardiovascularmortality in postmenopausal women, CIRCULATION, 103(25), 2001, pp. 3057-3061
Authors:
Filipeanu, CM
Henning, RH
de Zeeuw, D
Nelemans, A
Citation: Cm. Filipeanu et al., Intracellular Angiotensin II and cell growth of vascular smooth muscle cells, BR J PHARM, 132(7), 2001, pp. 1590-1596
Authors:
Jafar, TH
Schmid, CH
Landa, M
Giatras, I
Toto, R
Remuzzi, G
Maschio, G
Brenner, BM
Kamper, A
Zucchelli, P
Becker, G
Himmelmann, A
Bannister, K
Landais, P
Shahinfar, S
de Jong, PE
de Zeeuw, D
Lau, J
Levey, AS
Citation: Th. Jafar et al., Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data, ANN INT MED, 135(2), 2001, pp. 73-87
Authors:
Gansevoort, RT
de Zeeuw, D
Citation: Rt. Gansevoort et D. De Zeeuw, The antihypertensive and renal effects of angiotensin II receptor antagonists: remaining questions, CURR OP NEP, 9(1), 2000, pp. 57-61
Authors:
Broekroelofs, J
Stegeman, CA
Navis, GJ
de Haan, J
van der Bij, W
de Boer, WJ
de Zeeuw, D
de Jong, PE
Citation: J. Broekroelofs et al., Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable?, J HEART LUN, 19(3), 2000, pp. 256-262
Authors:
van Paassen, P
de Zeeuw, D
Navis, G
de Jong, PE
Citation: P. Van Paassen et al., Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function, NEPH DIAL T, 15(5), 2000, pp. 637-643
Authors:
Buter, H
van Tol, A
Navis, GJ
Scheek, LM
de Jong, PE
de Zeeuw, D
Dullaart, RPF
Citation: H. Buter et al., Angiotensin II receptor antagonist treatment lowers plasma total and very low plus low density lipoprotein cholesterol in Type 1 diabetic patients with albuminuria without affecting plasma cholesterol esterification and cholesteryl ester transfer, DIABET MED, 17(7), 2000, pp. 550-552
Authors:
Teisman, ACH
van Veldhuisen, DJ
Boomsma, F
de Kam, PJ
Tjeerdsma, G
Pinto, YM
de Zeeuw, D
van Gilst, WH
Citation: Ach. Teisman et al., Chronic beta-blocker treatment in patients with advanced heart failure - Effects on neurohormones, INT J CARD, 73(1), 2000, pp. 7-12
Authors:
Teisman, ACH
Westerink, BHC
van Veldhuisen, DJ
Scholtens, E
de Zeeuw, D
van Gilst, WH
Citation: Ach. Teisman et al., Direct interaction between the sympathetic and renin-angiotensin system inmyocardial tissue: a microdialysis study in anaesthetised rats, J AUTON NER, 78(2-3), 2000, pp. 117-121
Authors:
Teisman, ACH
Buikema, H
van Veldhuisen, FJ
de Zeeuw, D
van Gilst, WH
Citation: Ach. Teisman et al., Direct vasodilating effects of the new dopaminergic agonist Z1046 in humanarteries, J CARDIO PH, 35(4), 2000, pp. 581-585
Authors:
Bos, H
Andersen, S
Rossing, P
de Zeeuw, D
Parving, HH
de Jong, PE
Navis, G
Citation: H. Bos et al., Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy, KIDNEY INT, 57, 2000, pp. S32-S37
Authors:
Broekroelofs, J
Navis, GJ
Stegeman, CA
Van der Bij, W
de Boer, WJ
de Zeeuw, D
de Jong, PE
Citation: J. Broekroelofs et al., Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss, TRANSPLANT, 69(8), 2000, pp. 1624-1628
Authors:
Filipeanu, CM
Nelemans, A
Veldman, RJ
de Zeeuw, D
Kok, JW
Citation: Cm. Filipeanu et al., Regulation of [Ca2+](i) homeostasis in MRP1 overexpressing cells, FEBS LETTER, 474(1), 2000, pp. 107-110
Authors:
Hillege, HL
Girbes, ARJ
de Kam, PJ
Boomsma, F
de Zeeuw, D
Charlesworth, A
Hampton, JR
van Veldhuisen, DJ
Citation: Hl. Hillege et al., Renal function, neurohormonal activation, and survival in patients with chronic heart failure, CIRCULATION, 102(2), 2000, pp. 203
Authors:
Buikema, H
Monnink, SHJ
Tio, RA
Crijns, HJGM
de Zeeuw, D
van Gilst, WH
Citation: H. Buikema et al., Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure, BR J PHARM, 130(8), 2000, pp. 1999-2007